Schedule 13G ownership disclosure

VIRACTA THERAPEUTICS INC

Security class unavailable · CUSIP: 92765F108

Event date: 2021-02-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,901,152
Percent of class
7.8400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001683168-21-000788
Form type
SC 13G
Filer
LVP LIFE SCIENCE VENTURES III L.P.
CIK
CIK 1332654
Filed
Mar 05, 2021
Reporting period
Feb 25, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub